Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Wyeth-Ayerst acquires commercialization rights to rhIL-11

March 19, 1997

No Comments

Cabergoline launched in U.S.

March 19, 1997

No Comments

Preliminary clinical results with CI-1000

March 18, 1997

No Comments

Pharmacokinetics of paracalcin in patients undergoing hemodialysis

March 18, 1997

No Comments

Osiris Therapeutics awarded SBIR grant for tendon regeneration research

March 17, 1997

No Comments

Genzyme Transgenics and Fresenius to further development of transgenic albumin

March 17, 1997

No Comments

MGI Pharma and Schein reach marketing agreement for INFeD

March 14, 1997

No Comments

MP-52 enters clinic

March 14, 1997

No Comments

Combination of immunosuppression and rhIL-3 for aplastic anemia

March 14, 1997

No Comments

SKB discloses improved antihyperlipidemic agent

March 13, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Endocrine/metabolic
RSS

Wyeth-Ayerst acquires commercialization rights to rhIL-11

Cabergoline launched in U.S.

Preliminary clinical results with CI-1000

Pharmacokinetics of paracalcin in patients undergoing hemodialysis

Osiris Therapeutics awarded SBIR grant for tendon regeneration research

Genzyme Transgenics and Fresenius to further development of transgenic albumin

MGI Pharma and Schein reach marketing agreement for INFeD

MP-52 enters clinic

Combination of immunosuppression and rhIL-3 for aplastic anemia

SKB discloses improved antihyperlipidemic agent

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Cell mapping yields clues to metabolic health in obese individuals

Ionis notches Arrowhead win; Tryngolza cleared for FCS

Endocrine/metabolic RSS

Endocrine/metabolic
RSS